Tykerb News
Most Popular Tykerb Story
Tykerb - 2007 FDA approvals
Drug: Tykerb (lapatinib) Indication: Metastatic breast cancer Company: GlaxoSmithKline Approval Date: March 13, 2007 Scoop: The FDA gave its approval to Tykerb for metastatic breast cancer in... Read more...
Latest Headlines
- January 8, 2008
- November 15, 2006
- June 4, 2006
- May 23, 2006
- April 2, 2006
- November 29, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
